Integra LifeSciences

Forecast & Rating12 analysts currently cover Integra LifeSciences, with about 25.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $18.88, about 48.9% upside from the current price of $12.68. Price targets range from $14.00 to $27.00 — a wide spread, showing clear disagreement over just how much Integra LifeSciences can rise. Historically, about 29.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Integra LifeSciences's outlook. Data as of Oct 2, 2026; for reference only and not investment advice.